您所在的位置:首頁 > 心血管內(nèi)科醫(yī)學(xué)進展 > 研究發(fā)現(xiàn)血友病藥物可損害心臟
研究表明:利用大劑量的諾和諾德公司的抗凝血藥來治療非血友病的患者,比如出血中風(fēng),外傷,手術(shù),器官移植等,可能會提高心臟病發(fā)作的風(fēng)險。
The drug, NovoSeven, is a genetically engineered version of factor VII, a key protein missing in some people with the bleeding disease hemophilia.
Some doctors prescribe the drug in "off-label" use to stop unwanted bleeding associated with stroke, trauma, surgery, transplantation and other medical conditions. Doctors may prescribe any approved drug for any reason they want to.
近期,美國心臟學(xué)會(AHA)發(fā)布了家族性高膽固醇血癥的相關(guān)事宜的科學(xué)聲明,...[詳細]
糖尿病與冠心病互為高危因素。當(dāng)糖尿病與冠心病并存時,患者發(fā)生嚴(yán)重不良心血管...[詳細]
意見反饋 關(guān)于我們 隱私保護 版權(quán)聲明 友情鏈接 聯(lián)系我們
Copyright 2002-2024 Iiyi.Com All Rights Reserved